Julie L. Otte

Julie L. Otte

Auto-generated profile, based on publicly available information

Julie L. Otte

Christina L. Kiger, PhD, RN, is Director of Nurse Residency Programs, San Francisco Veterans Administration Health Care System, California

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2014 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
JOJulie L. Otte
Julie L. Otte
JCJanet S. Carpenter
Janet S. Carpenter
SMShalini Manchanda
Shalini Manchanda
KRKevin L. Rand
Kevin L. Rand
TSTodd C. Skaar
Todd C. Skaar
CLCarol Landis
Carol Landis
Although sleep is vital to all human functioning and poor sleep is a known problem in cancer, it is unclear whether the overall prevalence of the various types of sleep disorders in cancer is known. The purpose of this systematic literature review was to evaluate if the prevalence of sleep disorders could be ascertained from the current body of literature regarding sleep in cancer. This was a critical and systematic review of peer‐reviewed, English‐language, original articles published from 1980 through 15 October 2013, identified using electronic search engines, a set of key words, and prespecified inclusion and exclusion criteria. Information from 254 full‐text, English‐language articles was abstracted onto a paper checklist by one reviewer, with a second reviewer randomly verifying 50% (k = 99%). All abstracted data were entered into an electronic database, verified for accuracy, and analyzed using descriptive statistics and frequencies in SPSS (v.20) (North Castle, NY). Studies of sleep and cancer focus on specific types of symptoms of poor sleep, and there are no published prevalence studies that focus on underlying sleep disorders. Challenging the current paradigm of the way sleep is studied in cancer could produce better clinical screening tools for use in oncology clinics leading to better triaging of patients with sleep complaints to sleep specialists, and overall improvement in sleep quality.

4 May 2016 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
JOJulie L. Otte
Julie L. Otte
LDLorie Davis
Lorie Davis
JCJanet S. Carpenter
Janet S. Carpenter
CKConnie Krier
Connie Krier
TSTodd C. Skaar
Todd C. Skaar
SMShalini Manchanda
Shalini Manchanda

16 September 2015 in Climacteric
Verified
Journal Article
Closed access
PDF file
JCJ. S. Carpenter
J. S. Carpenter
NWN. F. Woods
N. F. Woods
JOJ. L. Otte
J. L. Otte
KGK. A. Guthrie
K. A. Guthrie
CHC. Hohensee
C. Hohensee
ALA. Z. LaCroix
A. Z. LaCroix
Objective To describe self-reported menopausal symptom priorities and their association with demographics and other symptoms among participants in an intervention trial for vasomotor symptoms (VMS). Methods Cross-sectional study embedded in the MsFLASH 02 trial, a three-by-two factorial design of yoga vs. exercise vs. usual activity and omega-3-fatty acid vs. placebo. At baseline, women (n = 354) completed hot flush diaries, a card sort task to prioritize symptoms they would most like to alleviate, and standardized questionnaires. Results The most common symptom priorities were: VMS (n = 322), sleep (n = 191), concentration (n = 140), and fatigue (n = 116). In multivariate models, women who chose VMS as their top priority symptom (n = 210) reported significantly greater VMS severity (p = 0.004) and never smoking (p = 0.012), and women who chose sleep as their top priority symptom (n = 100) were more educated (p ≤ 0.001) and had worse sleep quality (p < 0.001). ROC curves identified sleep scale scores that were highly predictive of ranking sleep as a top priority symptom. Conclusions Among women entering an intervention trial for VMS and with relatively low prevalence of depression and anxiety, VMS was the priority symptom for treatment. A card sort may be a valid tool for quickly assessing symptom priorities in clinical practice and research.

1 November 2015 in Menopause
Verified
Journal Article
Closed access
JOJulie L. Otte
Julie L. Otte
KRKevin L. Rand
Kevin L. Rand
CLCarol A. PhD Landis
Carol A. PhD Landis
MPMisti L. Paudel
Misti L. Paudel
KNKatherine M. Newton
Katherine M. Newton
JCJanet S. PhD Carpenter
Janet S. PhD Carpenter
Objective: Women, especially those with hot flashes, report poor sleep quality during various stages of the menopausal transition and postmenopause. Sleep measurements vary widely because of the copious instruments available. The Pittsburgh Sleep Quality Index (PSQI) is a frequently used questionnaire that produces a single score for sleep quality. This one-factor structure has not received consistent support in the literature. The goal of this analysis was to determine the best factor structure of the PSQI in women with hot flashes. Methods: A confirmatory factor analysis was conducted on PSQI baseline data from three randomized controlled clinical trials enrolling perimenopausal and postmenopausal women with hot flashes (N = 849) from the Menopause Strategies: Finding Lasting Answers for Symptoms and Health network. Several a priori factor models were compared. Results: One-factor and two-factor models did not fit the data. A three-factor model comprising sleep efficiency, perceived sleep quality, and daily disturbance showed good fit; however, the sleep medication item was dropped because of poor fit and low rates of sleep medication use. The three-factor model was examined in African-American and white subsamples and was found to be similar in both groups; however, two items showed small group differences in strength as indicators. Conclusions: Sleep quality in midlife women with hot flashes, as measured by the PSQI, seems to comprise three correlated factors. Minor measurement differences detected between groups are of research interest but do not necessitate different scoring practices. Additional research is needed to further define sleep quality and its associations with health-related outcomes.

15 April 2019 in Menopause
Verified
Journal Article
Closed access
JOJulie L. Otte
Julie L. Otte
GBGiorgos Bakoyannis
Giorgos Bakoyannis
KRKevin L. Rand
Kevin L. Rand
KEKristine E. Ensrud
Kristine E. Ensrud
KGKatherine A. Guthrie
Katherine A. Guthrie
JCJanet S. PhD Carpenter
Janet S. PhD Carpenter
Objective: Women's sleep at menopause is widely reported to be problematic. The Insomnia Severity Index (ISI) is a commonly used tool for quantifying sleep problems in clinical and research settings, but psychometric properties in postmenopausal women have not been reported. Our study aim was to examine the factor structure of the ISI in a large and diverse sample of midlife women with hot flashes. Methods: Baseline data were from 899 women enrolled in one of the three clinical trials using similar entry criteria conducted by the Menopause Strategies Finding Lasting Answers to Symptoms and Health research network. We conducted confirmatory factor analyses for the total sample and within strata defined by race/ethnicity (black and white women). Results: The ISI had two factors in the total sample. The two-factor structure was consistent across black and white women, with the exception of one item “difficulty falling asleep.” Conclusions: The ISI in midlife women with hot flashes is composed of two factors that capture dimensions of the insomnia severity and daytime impact. The instrument is a psychometrically sound scale appropriate for use in research and clinical practice to capture the severity and daytime impact of insomnia symptoms in diverse samples of midlife women with hot flashes. An abbreviated screening of two items could be considered to determine if further evaluation is needed of sleep complaints.

17 March 2020 in Journal of Women's Health
Verified
Journal Article
Closed access
JOJulie L. Otte
Julie L. Otte
JCJanet S. Carpenter
Janet S. Carpenter
LRLynae Roberts
Lynae Roberts
GEGary R. Elkins
Gary R. Elkins
Poor sleep is one of the most frequent health concerns among menopausal women. All stages of sleep can be impacted by the menopause transition. Negative outcomes of poor sleep are multidimensional and include poor physical, psychological, cognition, and social outcomes. Hypnosis is a nonpharmacological treatment for poor sleep and hot flashes in menopausal women. The goal of hypnosis is to educate and train subjects to perform self-hypnosis to alleviate the underlying symptom. The use of hypnosis as a treatment for poor sleep has shown benefits for both acute and chronic insomnia. Initial findings from the National Center for Complementary and Integrative Health (NCCIH) Hypnosis Intervention for Sleep in Menopause: Examination of Optimal Dose and Method of Delivery randomized control trial of 90 women were presented. Results showed that program and treatment satisfaction were high in all groups, adherence to daily practice met or exceeded adherence benchmarks. There were significant reduction of poor sleep quality in all groups with a significant increase in minutes slept in all groups. The majority of women also showed clinical improvements of duration. There were clinically meaningful improvements in reducing the perception of poor sleep quality in 50%–77% of women across time. Overall, the use of self-hypnosis as a treatment program for sleep problems related to menopause was acceptable for women. Data further support that hypnosis is a promising technique to improve sleep in menopausal women with sleep and hot flashes. Further research is ongoing on self-hypnosis delivery and implementation into wider populations of women using clear definition and control groups.